In patients with preeclampsia, placenta-derived, circulating soluble VEGF receptor and soluble endoglin inhibit VEGF- and BMP-9 signaling pathways leading to glomerular EC de-differentiation (3, 287, 288). Here, VEGFA is linked to preeclampsia.